MedTrace Logo

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

NCT02192619 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-02-23

No results posted yet for this study

Summary

The registry aims to document epidemiologic data, treatment and long-term outcome as well as quality of life of patients with APL. Additionally, a biobanking project for further translational studies is integrated.

Prospective population-based non-interventional and non-randomized multicenter registry.

Conditions

  • Newly-diagnosed APL (de Novo or Therapy-related)
  • Relapsed APL

Interventions

OTHER

observational

Sponsors & Collaborators

  • Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

    lead OTHER

Principal Investigators

  • Richard F. Schlenk, Prof. Dr. · Universitätsklinikum Ulm, for the AML-SG group

  • Eva Lengfelder, PD Dr. · Universitätsklinikum Mannheim

  • Dietger Niederwieser, Prof. Dr. · Universitätsklinikum Leipzig

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192619 on ClinicalTrials.gov